Illumina Ventures

Illumina Ventures Partner Mara Aspinall will host and moderate two key panels at the upcoming ASU Annual Diagnostics Summit hosted by the ASU College of Health Solutions. The summit convenes leaders from academia, industry, and government to discuss, debate, and decide the most relevant issues in #diagnostics.?? ?? ?? Date: Thursday, October 17, 2024? ? Time: 8am - 1pm PT? ?? Health Futures Center, Phoenix, AZ (In-person & Virtual)? ?? Featured Panels:? ?? ? Panel 1 | Smart Integration: Diagnostics, Drugs, Devices, and Data? ? Lunch Panel | Leading Diagnostics Companies at a Turbulent Time? ? Register here: https://lnkd.in/gbK8U3eU?

Our Partner Mara Aspinall recently shared her insights with the Arizona Daily Star regarding the underfunding of women entrepreneurs in connection with the new documentary, Show Her The Money. ??? ?? Mara highlighted the significant gap in venture capital for women-owned businesses and the need for change in the industry. Learn more about the conversation and the film here. https://lnkd.in/gYMk6x9d?

DELFI Diagnostics, a leader in next-generation blood-based #CancerDetection, has partnered with Allegheny Health Network (AHN) to evaluate the effectiveness of DELFI’s FirstLook blood test for #LungCancer screening. Using advanced whole-genome #MachineLearning, FirstLook analyzes cell-free DNA to help identify individuals at risk for lung cancer—the leading cause of cancer-related deaths worldwide.? ?? With a 99.8% negative predictive value, the test offers a more accessible way to improve early detection and patient outcomes. Learn more: https://lnkd.in/gSUCSyiX? ? #PartnerNews?

Congratulations to Integrated Biosciences, Inc.. on raising $17.2M in #SeedFunding to accelerate the development of its drug pipeline, further advance its technology platform, and ramp up its commercialization efforts.? ? As a pioneering #biotech company, Integrated Biosciences combines #SyntheticBiology and #AI-driven small-molecule #DrugDiscovery to develop next-gen #therapeutics for age-related diseases.? ?? Illumina Ventures Labs is proud to support this innovative team as they push the boundaries of drug discovery! ??? ? Read more in GenomeWeb: https://lnkd.in/gFgiXgww

Congratulations to LetsGetChecked, a leading global #healthcare solutions company, on its acquisition of digital pharmacy platform, Truepill. The acquisition strengthens LetsGetChecked’s ability to help healthcare partners deliver the best quality of care and improve health outcomes across their populations.? ? Learn more: https://lnkd.in/eEcdNPf4? ? #PartnerNews?

?? Congratulations to Iambic Therapeutics on being named to Endpoints News’ 11 Most Promising Biotech Startups! Iambic’s groundbreaking work with its #AI-driven discovery platform has led to rapid advancements in novel #therapeutics, including a clinical-stage lead program. ?? This recognition underscores Iambic’s transformative impact on #DrugDiscovery, and we’re excited to see their continued innovations in #oncology and beyond. ??? ? Read more: https://lnkd.in/gMuC8s67?

Illumina Ventures Partner, Ron Mazumder, will be attending the inaugural Johns Hopkins Innovation Summit in Baltimore on September 26.? ? Ron looks forward to learning about #biotech breakthroughs from the 14 #startups presenting that are emerging from The Johns Hopkins University research labs.? ? Event info: https://lnkd.in/g9UUpMN7?

Broken String Biosciences, a #genomics company enabling development of more precise, safe, and effective cell and gene therapies, has appointed Laurence Reid, PhD, as Chairman, and Brad Crutchfield as Non-Executive Director of its Board of Directors.? ? “Laurence and Brad bring distinguished careers and a strong history of driving impact and growth within our industry. It is a privilege to welcome them to the Broken String team,” said Felix Dobbs, PhD, CEO of Broken String Biosciences. “As we push forward with our ambitious growth strategy and work to achieve our commercial goals, their expertise will be instrumental in shaping our strategic direction.”? ? Read more: https://lnkd.in/e9kc4WRf? ? #PartnerNews #GeneTherapy?

Our Founding Partner, Nick Naclerio, and Partner, Mara Aspinall, will be attending the 2024 Nephron Healthcare Summit in Napa Valley from September 24-26 to dissect the industry’s most important trends and emergent themes.? ? Mara will join industry leaders, Brian J. Blaser, QuidelOrtho CEO,?and Norman Schwartz, Bio-Rad Laboratories?CEO, in the Dx CEO Roundtable, sharing insights on "Investing for the Mega-Trends in Diagnostics” on Wednesday, September 25, 8-8:50 am PT.?? ? See more info here: https://lnkd.in/dbxp6998? ? Nephron Research LLC?

?? Catch an inspiring 3-minute chat with Brian McKernan, CEO of Fluent BioSciences Inc., as he dives into the exciting impact of Fluent’s acquisition by Illumina! Discover how this partnership is set to transform the #healthcare landscape.? ?? Download the full conversation from our Spotlight series now ?? https://lnkd.in/gRnjX9gM ?? #PartnerNews #Biotech #SingleCell #Innovation??